A Randomized Double Blind Vehicle Controlled Dose Ranging Multiple Site Phase 2 Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Scalp Psoriasis
Phase of Trial: Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs Desoximetasone (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Taro Pharmaceuticals USA
- 19 Apr 2016 Status changed from recruiting to completed.
- 02 Nov 2015 Planned End Date changed from 1 Nov 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 02 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.